Injection d’Aracyt 1000 mg

Injection d’Aracyt 1000 mg is a vital medication containing Cytarabine, a potent antineoplastic agent. It is primarily used in the treatment of various types of leukemia, including acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Cytarabine works by interfering with DNA synthesis, thereby inhibiting the growth of cancer cells. This injectable formulation is administered intravenously or intrathecally, depending on the specific treatment protocol and the type of cancer being managed.

It is crucial to use Injection d’Aracyt 1000 mg under strict medical supervision due to its potential for significant side effects. Patients may experience myelosuppression (reduction in blood cell production), nausea, vomiting, diarrhea, and mucositis. Regular monitoring of blood counts and organ function is essential during treatment. This medication should be stored at room temperature, protected from light, and kept out of reach of children.